Velders Martina, Treff Gunnar, Machus Katja, Bosnyák Edit, Steinacker Jürgen, Schumann Uwe
Division of Sports and Rehabilitation Medicine, Ulm University Medical Center, Germany.
Department of Health Sciences and Sports Medicine, Semmelweis University, Budapest, Hungary.
Clin Biochem. 2014 Apr;47(6):471-4. doi: 10.1016/j.clinbiochem.2013.12.017. Epub 2013 Dec 27.
To elucidate cell free DNA (cfDNA) clearance kinetics following an acute bout of high intensity exercise by measuring circulating DNase activity reduction (AR).
Serum cfDNA concentration and DNase-AR were measured prior to and post (immediately post, 7 and 30 min post) an acute bout of rowing exercise until exhaustion.
Serum cfDNA concentration was significantly (P ≤ .001) elevated immediately post (2.5-fold) and 7 min post exercise (2.3-fold) with a return close to baseline at 30 min post exercise (1.5-fold). The rise in cfDNA was accompanied by a concomitant, significant (P ≤ .001) decrease in serum DNase-AR from 15.1% prior to exercise to 3.1% AR at cessation of the exercise test and 7 min post exercise (3.9% AR). DNase-AR returned close to baseline at 30 min post exercise (5.2% AR).
A single bout of high intensity exercise is a potent stimulus for enhancing circulating DNase activity in healthy people. Acute exercise may therefore be considered as a non-pharmacological stimulus to trigger DNase activity. This finding may be relevant for pathological conditions associated with increased cfDNA concentrations like cystic fibrosis, where pharmacological recombinant human DNase (rhDNase) treatment has been successfully used to improve patients' health and physical function.
通过测量循环脱氧核糖核酸酶活性降低(AR)来阐明急性高强度运动后游离DNA(cfDNA)的清除动力学。
在急性划船运动直至疲劳前及运动后(运动后即刻、运动后7分钟和30分钟)测量血清cfDNA浓度和脱氧核糖核酸酶-AR。
运动后即刻血清cfDNA浓度显著升高(P≤0.001)(2.5倍),运动后7分钟时升高(2.3倍),运动后30分钟时接近基线水平(1.5倍)。cfDNA升高的同时,血清脱氧核糖核酸酶-AR显著降低(P≤0.001),从运动前的15.1%降至运动测试结束时及运动后7分钟时的3.1%(AR)。运动后30分钟时,脱氧核糖核酸酶-AR接近基线水平(5.2% AR)。
单次高强度运动是增强健康人循环脱氧核糖核酸酶活性的有效刺激因素。因此,急性运动可被视为触发脱氧核糖核酸酶活性的非药物刺激因素。这一发现可能与诸如囊性纤维化等与cfDNA浓度升高相关的病理状况有关,在这些疾病中,药物重组人脱氧核糖核酸酶(rhDNase)治疗已成功用于改善患者健康和身体功能。